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Introduction
The Human Papillomavirus (HPV) is generally spread 
by sexual contacts [1]. The most frequent risk factors 
correlated with the infection and persistence of HPV in 
the population are the start of the first sexual contacts at 
young age, the number of sexual partners, the habit of 
smoking cigarettes and the utilization of some kinds of 
contraceptive methods [2, 3]. 
Two safe and effective vaccines against HPV infec-
tions, Gardasil® (Sanofi-Pasteur MSD) and Cervarix® 
(GlaxoSmithKline), were authorized and marketed in 
Europe and in Italy [4, 5]. Since January 11, 2007, the 
Italian Authorities decided to offer the HPV vaccine free 
of charge to all 12-year-old female adolescents, with a 
possible progressive extension of vaccination offer to a 
second cohort of women aged 25/26 years (at the time 
of the first cervical screening), and, according to avail-
ability of resources, to a third cohort of young women 
between 13 and 25 years [6, 7]. Furthermore, at the end 
of 2007, each Italian Region agreed to issue specific 
directives on implementation of vaccination strategies 
and, during 2008, all Italian Regions organized a vacci-
nation program against HPV for all 12 years-old girls [8, 
9]. However, in the absence of a unique national recom-
mendation, every Italian Region progressively adopted 
different strategies of vaccination for additional age 
groups of females (13-26 years) [9]. 
The Tuscan Regional Authorities, in addition to the ad-
ministration of HPV vaccine to 12 years-old girls, intro-
duced active and free of charge vaccination of 16 year-
old girls, while 13-15 year-old girls are free to opt for 
immediate immunization or to wait for the active call 
at 16 years. No co-payment policy was approved in the 
Region. Similar extensions of free-of-charge vaccina-
tion were deliberated by some other Regions (Basilicata, 
Piedmont, Valle d’Aosta) [10, 11]. On the other hand, 
other Regions only decided for the possibility of co-pay-
ment for some additional age groups.
An epidemiological study was therefore organized in or-
der to value the suitability of the different vaccination 
policies in Italy. The presence of previous risk factors 
for HPV infection in the young population aged 13-24 
years was analyzed. Important knowledge is expected 
from this study in order to provide indications for an op-
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Summary
The most frequent risk factors related to the infection/persistence 
of HPV in the population are an early start of sexual activity, 
the number of sexual partners, smoking, and the utilization of 
some contraceptive methods. In Italy, HPV vaccine is offered free 
of charge to all 12 year-old female adolescents, with a possible 
extension to other age groups according to Regional policies. 
In order to value the suitability of the current HPV vaccination 
strategies in Italy, an epidemiological study on sexual habits in 
adolescents and young adults was organized. An anonymous ques-
tionnaire on sexual behavior and risk factors for HPV infection 
was administered to 2300 students aged 13-24 years attending 
secondary schools and universities in Tuscany during 2008-09. 
About 12% of the sample declared to be foreign citizen. 
The results highlight the early start of sexual activity among young 
students. Particularly, more than half of the interviewed students 
declared to be already sexually active. The mean and the median 
age of the first sexual intercourse was 15.4 ± 1.4 years and 15 
years (25th and 75th percentiles = 14-16), respectively. More than 
77% of students at age 16 years declared they already had the 
first sexual intercourse, compared with 0.3% of those < 12 years. 
Generally, females aged 13-16-years, if sexually active, had sex-
ual contacts with a single partner. 
Most students declared to know common contraceptive methods 
(male condom and contraceptive pill). However, only half of them 
declared a regular use of male condom. These data confirm the 
importance of vaccination against HPV for young females before 
their sexual debut. In addition, the current multi-cohort strategy 
of HPV vaccination in Tuscany (free of charge in the age range 
12-16 years) allows also to catch up those girls that have not yet 
had their first sexual experiences before 16 years (21.5% accord-
ing to our study) but also to those girls already sexually active, 
who very rarely are already infected by all vaccine types at 16 
years. Our results also show the importance of sexual health edu-
cation and of promotion of correct behaviours in schools.
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timization and, possibly, harmonization of the vaccina-
tion strategy at the national level.
Materials and methods
A self-administered questionnaire was designed in order 
to study the sexual behavior and risk factors for HPV 
infection in Tuscan students attending the University 
of Florence (first year students) [12] and 6 secondary 
schools in Florence and Arezzo. The study population 
included students between 13 and 24 years old. Parental 
consent to take part to the enquiry was asked for all par-
ticipants under the age of 18 years.
After a short presentation on the objectives of this study 
and on HPV transmission routes (about 30 minutes) by 
public health physicians who remained available for 
further questions during questionnaire filling, question-
naires were distributed and anonymously self-filled by 
students. The questionnaire included 30 closed ques-
tions on demographic data of students, family-social 
status, sexual behaviours (age at the first sexual inter-
course, number of sexual partners, known and used 
contraception methods), reproductive history, smoking 
habits, previous sexual diseases. The questionnaire was 
anonymous in order to encourage openness and sincer-
ity in the answers on sensitive topics heavily impacting 
on personal privacy. Questionnaire data were inputed in 
a specifically created database (Excel 2010, Microsoft 
Inc.). Statistical analysis was performed by means of 
Excel software.
Results
Study population
The survey was carried out from May 2008 to May 2009 
and involved 2300 Tuscan students in the age range 13-
24 years (1692 females, 73.6%; 594 males, 25.8%; 14 
without declared gender, 0.6%). The subjects included 
in the sample represented 5.3% of people of the same 
age cohorts living in Florence and Arezzo. The study 
population was stratified by age group and gender (Tab. 
I). Considering all students irrespective of gender, the 
mean age ± S.D. was 16.6 ± 1.7 years, with a median age 
of 16 years. The mean age ± S.D. was 16.5 ± 1.7  years 
for females (median: 16 years) and 16.7 ± 1.8 years for 
males (median: 17 years). About 11.7% (268/2300) of 
the study population declared to be foreign: 134 students 
were non-Italian Europeans (Albanians and Romanians 
were particularly represented), 74 were Asian (mainly 
Chinese), 34 came from Central and Latin America and 
24 from Africa (Moroccans were the most represented 
group), and 2 subjects did not specified the nationality. 
The majority (63.2%) of students judged their own 
health status to be good, 17.0% excellent, 15.8% fairly 
good, 1.7% bad and 0.7% did not answer.
About 88% of students declared that the economic status 
of their family was satisfactory (8.0% deemed it very 
good, 31.7% good and 47.8% on average). 
Sexual activity
Table II shows the declared time of start of sexual activ-
ity, by age-group and gender: 2 students were excluded 
because sex and age were not declared. About 50% of 
all students (1152/2300) declared they already had the 
first sexual intercourse, 42.6% (982/2300) to be still vir-
gin, and 166/2300 (7.2%) did not answer the question. 
In particular, 48.4% of females and 54.7% of males had 
already started their sexual activity. In addition, most 
of females and males students ≥ 17-years (68.8% and 
70.5%, respectively) declared to be already sexually ac-
tive.
The mean age ± S.D. of declared sexual debut was 
15.4 ± 1.3 years for females and 15.3 ±1.5 years for 
males (median age 15 years for females and males). 
Considering all students irrespective of gender, the 
mean age ± S.D. of the first intercourse was 15.4 ± 
1.4 years, with a median age of 15 years (25th and 75th 
percentiles = 14-16 years). 
Figure 1 shows the age of sexual debut of all students 
by gender, while in Figure 2 we reported the cumulative 
probability of start of sexual activity by age group and 
by gender, using data on the age at first intercourse. It is 
noteworthy that 77.6% of students had already started 
their sexual activity at 16 years of age (78.5% of females 
and 75.4% of males), while only 0.1% of females and 
0.9% of males are sexually active before 12 years of age 
(Fig. 2). 
Tab. I. study population stratified by age group and gender (2 students excluded because sex and age were not declared).
Age group (years) Total number  
of students (%)
Female (%) Male (%) Gender not available 
(%)
13-16  
(%)
1154  
(50.2)
861 (50.9) 286 (48.1) 7  
(50.0)
17-19  
(%)
1024  
(44.6)
754 (44.6) 265 (44.6) 5  
(35.7)
20-24  
(%)
109  
(4.7)
69  
(4.14)
40  
(6.7)
0
age not available (%) 11  
(0.5)
8  
(0.5)
3  
(0.5)
2 (14.3)
Total number 2298 1692 594 14
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Tab. II. start of sexual activity of students, by age group and gender (2 students excluded because sex and age were not declared).
Sexual
Activity
Total 
students
Females Males Gender not 
available
13-16 17-19 20-24 Age not
available
13-16 17-19 20-24 Age not
available
13-16 17-19
yes (%)
(95% ci)
1152 
(50.1)
(48.0-52.2)
251 (29.2)
(26.1-32.2)
507 (67.2)
(63.8-70.7)
59 (85.5)
(77.0-94.0) 2 (25.0)
109 (38.1)
(32.4-43.9)
180 (67.9)
(62.2-73.7)
35 (87.5)
(77.0-98.0) 1 3 5
no (%)
(95% ci)
982 (42.6)
(40.6-44.8)
551 (64.0)
(60.7-67.3)
216 (28.6)
(25.4-31.9)
6 (8.7)
(1.9-15.5) 6 (75.0)
137 (47.9)
(42.0-53.8)
59 (22.3)
(17.2-27.4)
1 (2.5)
2 2
not
available 
(%)
(95% ci)
166 (7.2)
(6.1-8.3)
59(6.9)
(5.1-8.6)
31
(4.1)
(2.7-5.6)
4
(5.8)
(0.2-11.4) 0
40
(14.0)
(9.9-18.1)
26
(9.8)
(6.2-13.5)
4
(10.0)
(0.5-19.5) 2
Total 2300 861 754 69 8 286 265 40 3 7 5
Table III shows the data on the number of previ-
ous sexual partners, by age group and gender. 
A high percentage of females aged 13-16-years 
(58.2%) had had only one sexual partner, while 
students older than 17 years had generally had 
more than two previous partners. 
Among female participants who replied to be 
already sexually active, 27/819 (3.3%) de-
clared they had become pregnant at least once 
during their life: in almost all cases (74%) the 
pregnancy ended with an abortion.
Knowledge and utilization 
of contraceptive methods
Male condom and contraceptive pill were 
the most well-known contraceptive methods 
reported by sexually active students (96.7% 
and 86.5%, respectively) (Fig. 3). Other con-
traceptive methods (spermicidal, diaphragm, 
female condom, interrupted coitus and ab-
stention during fertile period) were know by 
less than 35% of sexually active students, 
with the exception of intrauterine devices 
(58.0%). 
About 74% of students declared they used a 
contraceptive method during the first sexual in-
tercourse (usually the male condom). Table IV 
and Table V show, respectively, the utilization 
of male condom and contraceptive pill among 
sexually active students during the last year and 
the year before the last one, by gender. In Table 
V, in the male group the contraceptive pill is ob-
viously used by the partner. 
Particularly, during the last year, about 57% of 
sexually active students declared the utiliza-
tion of male condom every time or almost all 
times during their sexual activity, and about 
19% of students used the contraceptive pill: 
these percentages were significantly higher 
than those declared for the previous year (p 
< 0.01).
Fig. 1. age of the first sexual intercourse of students, by gender in sexually 
active students.
Fig. 2. cumulative probability of sexual debut in students, by age. 
Fig. 3. knowledge of contraceptive methods reported by sexually active fe-
male and male students.
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Tab. III. distribution of number of partners, by gender and age-group, in sexually active students (11 students excluded because sex or age 
were not declared). 
Number of 
partners
Total 
students 
Females Males
13-16 years 17-19 years 20-24 years 13-16 years 17-19 years 20-24 years
1 (%)
(95% ci)
436 (38.2)
(35.3-41.1)
146 (58.2)
(51.9-64.4)
197 (38.9)
(34.5-43.2)
17 (28.8)
(17.0-40.6)
38 (34.9)
(25.7-44.0)
35 (19.4)
(13.5-25.3) 3 (8.6)
2-5 (%)
(95% ci)
458 (40.1)
(37.2-43.0)
70 (27.9)
(22.2-33.5)
228 (45.0)
(40.6-49.4)
31 (52.5)
(39.5-65.5)
38 (34.9)
(25.7-44.0)
74 (41.1)
(33.8-48.4)
17 (48.6)
(31.7-65.5)
>5 (%)
(95% ci)
130 (11.4)
(9.5-13.3)
14 (5.6)
(2.7-8.5)
49 (9.7)
(7.0-12.3)
10 (16.9)
(7.2-26.7)
14 (12.8)
6.4-19.3)
34 (18.9)
(13.1-24.7)
9 (25.7)
(10.9-40.5)
not available (%)
(95% ci)
117 (10.3)
(8.5-12.1)
21 (8.4)
(4.9-11.9)
33 (6.5)
(4.3-8.7) 1 (1.7)
19 (17.4)
(10.2-24.7)
37 (20.6)
(14.5-26.6)
6 (17.1)
(4.4-29.9)
Tab. IV. utilization of male condom among sensually active students during the previous and last year by gender. 
Use of male 
condom
Previous year Last year
Female Male Gender not 
available
Total Female Male Gender not
available
Total
every time (%)
(95% ci)
295 (36.0)
(32.7-39.4)
108 (33.2)
(28.0-38.5) 4 (50.0)
407 (35.3)
(32.5-38.1)
313 (38.2)
(34.8-41.6)
123 (37.8)
(32.5-43.2) 2 (25.0)
438 (38.0)
(35.2-40.9)
almost all times (%)
(95% ci)
136 (16.6)
(14.0-19.2)
57 (17.5)
(13.3-21.8) 1 (12.5)
194 (16.8)
(14.6-19.0)
153 (18.7)
(16.0-21.4)
61 (18.8)
(14.4-23.1) 1 (12.5)
215 (18.7)
(16.4-21.0)
sometime (%)
(95% ci)
82 (10.0)
(7.9-12.1)
36 (11.1)
(7.6-14.6) 2 (25.0)
120 (10.4)
(8.6-12.2)
92 (11.2)
(9.0-13.4)
32 (9.8)
(6.5-13.2) 2 (25.0)
126 (10.9)
(9.1-12.8)
rarely (%) 
(95% ci)
37 (4.5)
3.1-6.0)
15 (4.6)
(2.3-6.9) 1 (12.5)
53 (4.6)
(3.4-5.8)
53 (6.5)
(4.8-8.2)
21 (6.5)
(3.7-9.2) 1 (12.5)
75 (6.5)
(5.1-8.0)
never (%)
(95% ci)
44 (5.4)
(3.8-6.9)
23 (7.1)
(4.2-9.9) 0
67 (5.8)
(4.4-7.2)
63 (7.7)
(5.8-9.6)
16 (4.9)
(2.5-7.3) 1 (12.5)
80 (6.9)
(5.4-8.4)
non-responder (%)
(95% ci)
225 (27.5)
(24.4-30.6)
86 (26.5)
(21.6-31.4) 0
311 (27.0)
(24.4-29.6)
145 (17.7)
(15.0-20.4)
72 (22.2)
(17.5-26.8) 1 (12.5)
218 (18.9)
(16.6-21.2)
total 819 325 8 1152 819 325 8 1152
Tab. V. utilization of contraceptive pill among sensually active students during the previous and last year by gender (in the male group the 
contraceptive pill is used by partner). 
Use of
contraceptive pill
Previous year Last year
Female Male Gender not 
available
Total Female Male Gender not
available
Total
every time (%)
(95% ci)
98 (12.0)
(9.7-14.2)
22 (6.8)
(4.0-9.6) 1 (12.5)
121 (10.5)
(8.7-12.3)
151 (18.4)
(15.7-21.1)
26 (8.0)
(5.0-11.0) 0
177 (15.4)
(13.2-17.5)
almost all times (%)
(95% ci)
17 (2.1)
(1.1-3.1)
10 (3.1)
(1.2-5.0) 0
27 (2.3)
(1.5-3.2)
24 (2.9)
(1.8-4.1)
17 (5.2)
(2.8-7.7) 1 (12.5)
42 (3.6)
(2.5-4.8)
sometime (%)
(95% ci)
14 (1.7)
(0.8-2.6)
14 (4.3)
(2.1-6.6) 1 (12.5)
29 (2.5)
(1.6-3.4)
20 (2.4)
(1.4-3.5)
23 (7.1)
(4.2-9.9) 1 (12.5)
44 (3.8)
(2.7-4.9)
rarely (%)
(95% ci)
17 (2.1)
(1.1-3.1)
21 (6.5)
(3.7-9.2) 0
38 (3.3)
(2.2-4.4)
11 (1.3)
(0.5-2.1)
21 (6.5)
(3.7-9.2) 0
32 (2.8)
(1.8-3.7)
never (%)
(95% ci)
412 (50.3)
(46.8-53.8)
162 (49.8)
(44.3-55.4) 4 (50.0)
578 (50.2)
(47.2-53.1)
454 (55.4)
(52.0-58.9)
164 (50.5)
(44.9-56.0) 4 (50.0)
622 (54.0)
(51.1-56.9)
non-responder (%)
(95% ci)
261 (31.9)
(28.6-35.1)
96 (29.5)
(24.5-34.6) 2  (25.0)
359 (31.2)
(28.4-33.9)
159 (19.4)
(16.6-22.2)
74 (22.8)
(18.1-27.4) 2 (25.0)
235 (20.4)
(18.0-22.8)
total 819 325 8 1152 819 325 8 1152
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Other risk factors for HPV infection
About 7% of students (162/2300: 137 females, 22 males 
and 3 students without gender information) experienced 
at least one genital infectious disease during their life 
(the infection by Candida albicans being the most fre-
quently declared disease by 63/162 students, 38.9%): 6 
students reported a previous infection by HPV. 
About 68.3% of students (1572/2300) had smoked 
cigarettes at least once during their life: 70.1% 
(1186/1692) of females and 63.6% (378/594) of males, 
respectively. Among those students who had expe-
rienced smoking cigarettes at least once during their 
life, 53.9% (847/1572) were smoking at the time of 
questionnaire filling. Smoking students smoke an av-
erage of 53 cigarettes in one week. The average age of 
the first smoked cigarette among at least once smok-
ers was 14 years ± 1.8, while the mean age of start of 
regular smoke was 15 years ± 1.6. 
Validation of the study
About 89.5% of students (2059/2300) judged very easy 
to fill the questionnaire (90.9% of Italian students and 
80.6% of foreigners). In addition, 77.9% of subjects 
(1792/2300) considered filling this questionnaire useful 
in order to investigate the sexual behavior of the younger 
generations and for obtaining information on the trans-
mission of sexual infections (79.4% of Italian students 
and 67.5% of foreign ones). 
Discussion and conclusions
Almost three quarters of students involved in this study 
were females, that are the target population of HPV vac-
cination and represent a useful sample to evaluate indi-
rectly the suitability of the current vaccination strategies 
in Tuscany, Italy.
The results of this study highlight the early start of 
sexual activity among young students in Tuscany, as 
shown in other Italian geographic areas involved in this 
study [13].
Particularly, more than half of interviewed students de-
clared to be already sexually active. The mean and me-
dian age of the sexual debut is about 15 years: 77.6% 
of students at 16 years declared to have had already the 
first sexual intercourse, compared with 0.3% of students 
younger than 12 years (p < 0.01). These data confirm 
the importance of vaccination against HPV for young 
females aged 12-16 years, before their sexual debut. 
Particularly, the current strategy of vaccination against 
HPV involving more than one cohort, adopted in the 
Tuscany Region (12-16 year-old females) [11], is likely 
to provide additional benefits: it will allow also to catch 
up girls that had not had yet the first sexual experiences 
until 16 years (21.5%) and/or did not experience pre-
vious infections by HPV yet. These considerations are 
additionally supported by the number of sexual part-
ners declared by students: generally females aged 13-16 
years had sexual contacts with only one partner, while 
students ≥17-years declared they had had at least two 
partners during their life.
Tuscan students showed good knowledge of the most usu-
al contraceptive methods (particularly, male condom and 
contraceptive pill). Although male condom use does not 
provide total protection against HPV infections, it consid-
erably reduces the risk of spreading them [14-17]. How-
ever, only half of involved students declared to use male 
condom (the most widely used contraceptive method) 
regularly. This low use of condoms may lead to a greater 
circulation of HPV among adolescents, and consequently, 
to a higher probability of infection by HPV genotypes at 
high risk (16 and 18). 
Our data are in line with the results obtained in Ligu-
ria, where the same questionnaire was administered 
to a similar target population [13]: in particular an in-
crease in the percentage of sexually active people in 
the youngest age groups (13-16 years), is more and 
more evident with time, also comparing our data with 
those obtained in past studies in Italy and other Euro-
pean Countries [18-25]. Furthermore, the trend towards 
an earlier sexual debut, is also confirmed by a recent 
update on sexual behavior in young adults reported in 
some European countries [26]. 
For these reasons, and taking into account that HPV 
vaccination in female adolescents before or immedi-
ately after their sexual debut is effective in reducing the 
overall risk of developing cervical cancer [27], the most 
suitable vaccination program for Italy seems to be in-
creasing coverage in cohorts involved in the present na-
tional vaccination strategy (immunization of 12-years-
old girls), complemented by a temporary active offer of 
vaccination to female adolescents aged 13-16 years, that 
was already implemented in the Tuscany Region. If eco-
nomically and logistically feasible, a multi-cohort vac-
cination strategy, involving a large pool of susceptible 
females in a short time, would rapidly reduce the cir-
culation of the vaccine-types viruses and, consequently, 
have a higher clinical impact on diseases related to those 
high-risk HPV types. 
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